A study of 500,000 COVID-19 patients found CVST had occurred at a rate of 39 people out of a million following infection, researchers said....

Sri Lanka launched its inoculation programme in late January when India gifted 500,000 doses of Oxford-AstraZeneca. Till Thursday 913,219 p...

The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have origina...

SII, the world’s largest vaccine manufacturer by volume, is mass producing the AstraZeneca vaccine, developed with Oxford University, for d...

Developers of the Oxford-AstraZeneca vaccine expect to have a modified jab to cope with the South Africa coronavirus variant by autumn, the...

Regulatory endorsement is a welcome boost for AstraZeneca and the Oxford team, which have been accused of a lack of clarity about the resul...

The UK government announced on December 23 that the developers of the Oxford AstraZeneca vaccine had submitted their data to the Medicines ...

SII has already manufactured around 50 million doses of its Covid vaccine called Covishield, which is based on the technology from drugmake...

The two sets of experts are to join forces to explore if a combination of the two jabs, both using a benign virus called adenovirus, could ...

AstraZeneca Chief Executive Officer Pascal Soriot said the drugmaker had begun submitting data to regulatory authorities around the world t...

"I don't think there is any reason to be unduly concerned," British housing minister Robert Jenrick told Sky News. "We have now written to ...

Pharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the...

The study had been previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it ...

"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and wil...

Last month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...

The sources told that the Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials...

HEALTH-CORONAVIRUS-OXFORD-VACCINE-Positive news on Oxford/AstraZeneca COVID-19 vaccine could come Thursday: report